Armstrong Advisory Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6K Hold
75
﹤0.01% 631
2026
Q1
$22.2K Hold
75
﹤0.01% 541
2025
Q4
$20.5K Hold
75
﹤0.01% 553
2025
Q3
$20.3K Hold
75
﹤0.01% 562
2025
Q2
$20.7K Hold
75
﹤0.01% 534
2025
Q1
$17.4K Hold
75
﹤0.01% 544
2024
Q4
$17.4K Hold
75
﹤0.01% 544
2024
Q3
$16.5K Hold
75
﹤0.01% 535
2024
Q2
$14.7K Sell
75
-25
-25% -$5.17K ﹤0.01% 540
2024
Q1
$21.1K Hold
100
﹤0.01% 475
2023
Q4
$21.1K Hold
100
﹤0.01% 475
2023
Q3
$20K Buy
100
+50
+100% +$9.94K ﹤0.01% 487
2023
Q2
$9.27K Hold
50
﹤0.01% 589
2023
Q1
$9.58K Hold
50
﹤0.01% 580
2022
Q4
$8.41K Buy
+50
New +$8.69K ﹤0.01% 611

Other funds holding CME

Armstrong Advisory Group's CME Position: Q2 2026 in Review

Armstrong Advisory Group held its CME Group (CME) position steady in Q2 2026 at 75 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #631.

Armstrong Advisory Group first reported a position in CME in Q4 2022 and has held it in 15 quarters since. The position peaked at $22.2K in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Armstrong Advisory Group held 75 shares of CME Group worth $16.6K as of Q2 2026.
  • Armstrong Advisory Group left its CME Group share count unchanged in Q2 2026.
  • CME Group made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #631 holding.
  • Armstrong Advisory Group first reported a position in CME Group in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's CME Group position peaked at $22.2K in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.